You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

List of Excipients in API estrogens, conjugated


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing estrogens, conjugated

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc PREMARIN estrogens, conjugated 0046-1101 CARNAUBA WAX
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc PREMARIN estrogens, conjugated 0046-1101 CELLULOSE, MICROCRYSTALLINE
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc PREMARIN estrogens, conjugated 0046-1101 FD&C BLUE NO. 2
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc PREMARIN estrogens, conjugated 0046-1101 HYDROXYPROPYL CELLULOSE
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc PREMARIN estrogens, conjugated 0046-1101 HYPROMELLOSE 2208
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc PREMARIN estrogens, conjugated 0046-1101 HYPROMELLOSE 2910
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc PREMARIN estrogens, conjugated 0046-1101 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing estrogens, conjugated

Company Ingredient NDC Excipient
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387 CELLULOSE, MICROCRYSTALLINE
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387 D&C YELLOW NO. 10 ALUMINUM LAKE
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387 FD&C BLUE NO. 2 ALUMINUM LAKE
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387 HYPROMELLOSES
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387 LACTOSE MONOHYDRATE
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387 MAGNESIUM STEARATE
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387 POLYETHYLENE GLYCOL 400
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for estrogens, conjugated

Excipient focus: CALCIUM HYDROXYAPATITE

Excipient focus: CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

estrogens, conjugated drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Wyeth Pharmaceuticals LLC a subsidiary of Pfizer Inc estrogens, conjugated 0046-1101
A-S Medication Solutions estrogens, conjugated 50090-0167
A-S Medication Solutions estrogens, conjugated 50090-1853
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-387
Ingenus Pharmaceuticals LLC estrogens, conjugated 50742-390
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: COPERNICIA CERIFERA

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C BLUE NO. 2 ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE 2208

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: PEG-8

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POVIDONE

Excipient focus: POWDERED CELLULOSE

Excipient focus: SODIUM ACETATE ANHYDROUS

Excipient focus: SUCROSE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIBASIC CALCIUM PHOSPHATE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links